Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29126 - 29150 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	KIF2C	11004	downregulated	Dasatinib results in decreased expression of KIF2C mRNA	1p34.1	A21899
Dasatinib	Approved Investigational	KIF4A	24137	downregulated	Dasatinib results in decreased expression of KIF4A mRNA	Xq13.1	A21899
Dasatinib	Approved Investigational	KIFC1	3833	downregulated	Dasatinib results in decreased expression of KIFC1 mRNA	6p21.32	A21899
Dasatinib	Approved Investigational	KNSTRN	90417	downregulated	Dasatinib results in decreased expression of KNSTRN mRNA	15q15.1	A21899
Dasatinib	Approved Investigational	KNTC1	9735	downregulated	Dasatinib results in decreased expression of KNTC1 mRNA	12q24.31	A21899
Dasatinib	Approved Investigational	KPNA2	3838	downregulated	Dasatinib results in decreased expression of KPNA2 mRNA	17q24.2	A21899
Dasatinib	Approved Investigational	LAMB1	3912	upregulated	Dasatinib results in increased expression of LAMB1 mRNA	7q31.1	A21899
Dasatinib	Approved Investigational	LBH	81606	upregulated	Dasatinib results in increased expression of LBH mRNA	2p23.1	A21899
Dasatinib	Approved Investigational	LIMCH1	22998	upregulated	Dasatinib results in increased expression of LIMCH1 mRNA	4p13	A21899
Dasatinib	Approved Investigational	LINC00312	29931	upregulated	Dasatinib results in increased expression of LINC00312 mRNA	3p25.3	A21899
Dasatinib	Approved Investigational	LMCD1	29995	upregulated	Dasatinib results in increased expression of LMCD1 mRNA	3p25.3	A21899
Dasatinib	Approved Investigational	LMNB1	4001	downregulated	Dasatinib results in decreased expression of LMNB1 mRNA	5q23.2	A21899
Dasatinib	Approved Investigational	LMOD1	25802	upregulated	Dasatinib results in increased expression of LMOD1 mRNA	1q32.1	A21899
Dasatinib	Approved Investigational	LPXN	9404	downregulated	Dasatinib results in decreased expression of LPXN mRNA	11q12.1	A21899
Dasatinib	Approved Investigational	LRP1	4035	upregulated	Dasatinib results in increased expression of LRP1 mRNA	12q13.3	A21899
Dasatinib	Approved Investigational	LRR1	122769	downregulated	Dasatinib results in decreased expression of LRR1 mRNA	14q21.3	A21899
Dasatinib	Approved Investigational	LSAMP	4045	upregulated	Dasatinib results in increased expression of LSAMP mRNA	3q13.31	A21899
Dasatinib	Approved Investigational	LUM	4060	upregulated	Dasatinib results in increased expression of LUM mRNA	12q21.33	A21899
Dasatinib	Approved Investigational	MAD2L1	4085	downregulated	Dasatinib results in decreased expression of MAD2L1 mRNA	4q27	A21899
Dasatinib	Approved Investigational	MALL	7851	downregulated	Dasatinib results in decreased expression of MALL mRNA	2q13	A21899
Dasatinib	Approved Investigational	MAMDC2	256691	upregulated	Dasatinib results in increased expression of MAMDC2 mRNA	9q21.12	A21899
Dasatinib	Approved Investigational	MASTL	84930	downregulated	Dasatinib results in decreased expression of MASTL mRNA	10p12.1	A21899
Dasatinib	Approved Investigational	MCAM	4162	upregulated	Dasatinib results in increased expression of MCAM mRNA	11q23.3	A21899
Dasatinib	Approved Investigational	MCM10	55388	downregulated	Dasatinib results in decreased expression of MCM10 mRNA	10p13	A21899
Dasatinib	Approved Investigational	MCM6	4175	downregulated	Dasatinib results in decreased expression of MCM6 mRNA	2q21.3	A21899

Displaying entries 29126 - 29150 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability